Moreover, Bregs might disable the cellular immune response against the tumor by promoting the conversion of CD4+/CD25− T lymphocytes to FoxP3+ Tregs, thereby, enabling tumor growth and the development of metastasis. Here, CD4 is linked to neoplasm.